Dermatofibrosarcoma protuberans: pathology, genetics, and potential therapeutic strategies
Top Cited Papers
- 1 December 2016
- journal article
- review article
- Published by Elsevier BV in Annals of Diagnostic Pathology
- Vol. 25, 64-71
- https://doi.org/10.1016/j.anndiagpath.2016.09.013
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimicsLaboratory Investigation, 2014
- Dermatofibrosarcoma protuberans (DFSP) successfully treated with sorafenib: case reportClinical Sarcoma Research, 2013
- Advances in Molecular Characterization and Targeted Therapy in Dermatofibrosarcoma ProtuberansSarcoma, 2011
- Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical TrialsJournal of Clinical Oncology, 2010
- The Impact of Advances in Molecular Genetic Pathology on the Classification, Diagnosis and Treatment of Selected Soft Tissue Tumors of the Head and NeckHead and Neck Pathology, 2010
- Role of platelet-derived growth factors in physiology and medicineGenes & Development, 2008
- Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002Journal of the American Academy of Dermatology, 2007
- Outcomes of surgery for dermatofibrosarcoma protuberansEuropean Journal of Surgical Oncology, 2004
- Dermatofibrosarcoma protuberansJournal of the American Academy of Dermatology, 1996
- Dermatofibrosarcoma protuberans of the scalp: A series of casesJournal of the American Academy of Dermatology, 1989